|
|
|
|
|
|
|
Can-Fite BioPharma Ltd. (CANF)
|
|
1.27 0 (0%)
|
12-14 16:00
|
|
Open:
|
1.27
|
Pre. Close:
|
1.27
|
|
High:
|
1.3
|
Low:
|
1.27
|
|
Volume:
|
18,854
|
Market Cap:
|
26M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.301 - 1.308
|
1.308 - 1.313
|
|
Low:
|
1.255 - 1.262
|
1.262 - 1.268
|
|
Close:
|
1.269 - 1.28
|
1.28 - 1.29
|
|
|
|
Technical analysis (as of: 2018-12-14 4:22:48 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 1.79 One year: 2.02
|
|
Support:
|
Support1: 1.22 Support2: 1.02
|
|
Resistance:
|
Resistance1:
1.54 Resistance2: 1.73
|
|
Pivot:
|
1.33 
|
|
Moving Averages:
|
MA(5): 1.28 MA(20): 1.36
MA(100): 1.29 MA(250): 1.44
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.01
|
|
%K %D:
|
%K(14,3): 13.25 %D(3): 12.04
|
|
RSI:
|
RSI(14): 44.75
|
|
52-Week:
|
High: 2.75
Low: 1.12 Change(%): -3.0
|
|
Average Vol(K):
|
3-Month: 10394
10-Days 6405
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CANF has closed above bottom band by 32.8%. Bollinger Bands are 71.4% wider than normal. The large width of the bands suggest high volatility as compared to CANF's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-12-10T08:35:23-05:00
Can-Fite collaborates with Icahn School of Medicine, NYC to explore namodenoson's anti-NASH effect
2018-12-10T07:00:00-05:00
Can-Fite Enters Into Collaboration Agreement to Explore Namodenoson's Anti-NASH Effect With Icahn School of Medicine at Mount Sinai in NYC
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
